chr11-62707136-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001122955.4(BSCL2):āc.60C>Gā(p.Asp20Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00688 in 1,554,368 control chromosomes in the GnomAD database, including 622 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D20H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001122955.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BSCL2 | NM_001122955.4 | c.60C>G | p.Asp20Glu | missense_variant | 1/11 | ENST00000360796.10 | |
HNRNPUL2-BSCL2 | NR_037946.1 | n.2580C>G | non_coding_transcript_exon_variant | 14/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BSCL2 | ENST00000360796.10 | c.60C>G | p.Asp20Glu | missense_variant | 1/11 | 1 | NM_001122955.4 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0369 AC: 5604AN: 151928Hom.: 347 Cov.: 33
GnomAD3 exomes AF: 0.00831 AC: 1346AN: 162046Hom.: 61 AF XY: 0.00642 AC XY: 548AN XY: 85336
GnomAD4 exome AF: 0.00362 AC: 5077AN: 1402322Hom.: 275 Cov.: 31 AF XY: 0.00320 AC XY: 2211AN XY: 691666
GnomAD4 genome AF: 0.0369 AC: 5612AN: 152046Hom.: 347 Cov.: 33 AF XY: 0.0351 AC XY: 2612AN XY: 74332
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 19, 2017 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Jan 25, 2019 | ACMG criteria: BA1 (14% in Africans, seen in previous cases, similar freq in Today/1000g), BS2 (22 homozygotes in ExAC)= benign (REVEL 0.224 and 7 predictors/BP4: conflicing evidence, not using) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at